Medicine & Life Sciences
Neoplasms
100%
Breast Neoplasms
42%
Therapeutics
41%
Survival
39%
Radiotherapy
34%
Drug Therapy
28%
Neoplasm Metastasis
28%
Genes
24%
Mutation
20%
Melanoma
19%
Prostatic Neoplasms
19%
Recurrence
18%
Acute Myeloid Leukemia
18%
Proteins
17%
Radiation
17%
Non-Small Cell Lung Carcinoma
17%
Carcinoma
17%
Apoptosis
16%
Lung Neoplasms
16%
Growth
16%
T-Lymphocytes
15%
Ovarian Neoplasms
15%
Adenocarcinoma
15%
Pancreatic Neoplasms
14%
Cell Line
14%
Breast
13%
Lung
13%
Clinical Trials
13%
Biomarkers
13%
Colorectal Neoplasms
12%
Leukemia
12%
Immunotherapy
12%
DNA
11%
Glioma
11%
Confidence Intervals
11%
B-Cell Chronic Lymphocytic Leukemia
11%
Progression-Free Survival
11%
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
10%
Carcinogenesis
10%
In Vitro Techniques
10%
Liver
10%
Glioblastoma
10%
Population
10%
Renal Cell Carcinoma
9%
Lymphoma
9%
Bone Marrow
9%
Gene Expression
9%
Sarcoma
9%
Head and Neck Neoplasms
9%
Phosphotransferases
9%
Safety
9%
Pharmaceutical Preparations
9%
Guidelines
9%
Squamous Cell Carcinoma
9%
MicroRNAs
9%
ErbB Receptors
9%
Stem Cells
9%
Skin
9%
Cancer Survivors
8%
Protein-Tyrosine Kinases
8%
Proton Therapy
8%
Lymph Nodes
8%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8%
Multiple Myeloma
8%
Phosphorylation
8%
Phenotype
8%
Imatinib Mesylate
8%
Transplants
8%
Cisplatin
8%
Myelodysplastic Syndromes
8%
Urinary Bladder Neoplasms
8%
Incidence
7%
Radiation Oncology
7%
Doxorubicin
7%
Biopsy
7%
Tomography
7%
Brain
7%
Mortality
7%
Prostate
7%
DNA Repair
7%
Neck
7%
Hepatocellular Carcinoma
7%
DNA Damage
7%
Genome
7%
Paclitaxel
7%
Squamous Cell Carcinoma of Head and Neck
7%
Ligands
6%
Brain Neoplasms
6%
Hematologic Neoplasms
6%
Down-Regulation
6%
Head
6%
Protons
6%
Pediatrics
6%
Odds Ratio
6%
Messenger RNA
6%
Quality of Life
6%
Infections
6%
Uterine Cervical Neoplasms
6%
Heterografts
6%
Cell Proliferation
6%